等待開盤 12-15 09:30:00 美东时间
0.000
0.00%
Tariffs and lower demand for farming equipment are two risks weighing on Deere stock.
11-26 01:11
President Donald Trump said U.S. cattle ranchers "don't understand" how tariffs have benefited them, and insisted that they need to lower their prices. "The Cattle Ranchers, who I love, don't understa...
10-23 15:48
MOORESVILLE, N.C., Oct. 9, 2025 /PRNewswire/ -- Lowe's Companies, Inc. ("Lowe's" or the "Company") (NYSE: LOW) today announced that the Company has completed its previously announced acquisi...
10-09 19:30
U.S. wheat and corn futures fell sharply Tuesday after the U.S. Department of Agriculture's quarterly report showed bigger than expected stockpiles. The USDA showed wheat and corn stocks came in highe...
10-01 06:40
MOORESVILLE, N.C. , Aug. 29, 2025 /PRNewswire/ -- The board of directors of Lowe's Companies, Inc. (NYSE: LOW) has declared a quarterly cash dividend of one dollar and 20 cents ($1.20) per s...
08-30 04:30
MOORESVILLE, N.C., Aug. 26, 2025 /PRNewswire/ -- Lowe's Companies, Inc. (NYSE: LOW) announces that Marvin R. Ellison, chairman and chief executive officer, will participate in a fireside cha...
08-27 04:30
— Diluted EPS of $4.27; Adjusted Diluted EPS1 of $4.33 — — Comparable Sales increased 1.1% — — Updates Full Year 2025 Outlook — MOORESVILLE, N.C., Aug. 20, 2025 /PRNewswire/ -- Lowe's Compa...
08-20 18:00
Moomoo, a global investment and trading platform, successfully secured IPO shares for all its subscribers in the Bullish IPO. The platform offers comprehensive research tools, including Moomoo AI, an advanced chatbot providing expert-level analysis on stocks, ETFs, and IPOs. Additionally, Moomoo fosters a community-driven environment for investors to exchange insights and refine strategies. CEO Neil McDonald emphasized Moomoo's commitment to demo...
08-14 12:00
<p>GRI Bio, Inc. announced that its CEO, Marc Hertz, participated in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference. The video webcast is available on virtualinvestorco.com and the Company's website. GRI Bio focuses on NKT cell modulators for treating inflammatory, fibrotic, and autoimmune diseases, with its lead program, GRI-0621, targeting idiopathic pulmonary fibrosis.</p>
07-22 12:45
GRI Bio, Inc. has completed patient enrollment for its Phase 2a study of GRI-0621 for treating Idiopathic Pulmonary Fibrosis (IPF). The interim safety results from 2 and 6 weeks showed GRI-0621 to be safe and well-tolerated in 12 and 24 patients, respectively. No hyperlipidemia was observed, and biomarker changes suggest an anti-fibrotic effect. The company expects to report 6-week interim biomarker data in July 2025 and topline results in Q3 202...
07-01 12:45